Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Articles

Correspondence

Clinical Implications of Discordant FIB-4 and LSM in MASLD: Integrating Evidence and Optimizing Pathways: Authors’ reply

Terry Cheuk-Fung Yip1,2,3, Vincent Wai-Sun Wong1,2, Seung Up Kim4
Published online: January 27, 2026
1Medical Data Analytics Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
2State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China
3Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China
4Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea
Corresponding author:  Terry Cheuk-Fung Yip, Tel: 852-3505-3125, 
Email: tcfyip@cuhk.edu.hk
Received: 16 January 2026   • Accepted: 17 January 2026
  • 598 Views
  • 9 Download
  • 0 Crossref
  • 0 Scopus

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

Clinical Implications of Discordant FIB-4 and LSM in MASLD: Integrating Evidence and Optimizing Pathways: Authors’ reply
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
Clinical Implications of Discordant FIB-4 and LSM in MASLD: Integrating Evidence and Optimizing Pathways: Authors’ reply
Close